机译:复发评分有助于选择T1-2N1乳腺癌患者进行个性化后切除术放射治疗 - 两位机构2793名患者的联合分析
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
Sun Yat Sen Univ Collaborat Innovat Ctr Canc Med State Key Lab Oncol South China Dept Radiat;
PUMC Beijing Peoples R China;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
Sun Yat Sen Univ Ctr Canc State Key Lab Oncol South China Collaborat Innovat Ctr Canc Med;
CAMS Canc Hosp Natl Clin Res Ctr Canc State Key Lab Mol Oncol Natl Canc Ctr Beijing Peoples R;
机译:复发评分有助于选择T1-2N1乳腺癌患者进行个性化后切除术放射治疗 - 两位机构2793名患者的联合分析
机译:在T1-2N0M0,雌激素受体阳性,人体表皮生长受体2阴性侵袭性乳腺癌中将复发评分纳入美国联合委员会纳入美国联合委员会的评估:基于人群的分析
机译:在T1-2N0M0,雌激素受体阳性,人体表皮生长受体2阴性侵袭性乳腺癌中将复发评分纳入美国联合委员会纳入美国联合委员会的评估:基于人群的分析
机译:预后因素对乳腺癌患者后切除辐射治疗的影响
机译:乳房切除术后患者自体组织与基于义肢的乳房重建术之间的患者满意度和生活质量分析。
机译:AJCC第8版分期系统的有效性选择T1-2N1乳腺癌乳腺切除放疗患者的患者:1986名院校患者的联合分析
机译:复发评分有助于选择T1-2N1乳腺癌患者进行个性化后切除术放射治疗 - 两位机构2793名患者的联合分析